HDAC6 is either weakly expressed or undetectable in 96% of DLBCL cases (125) and HDAC6 may be an important prognostic marker associated with a good outcome in DLBCL or a more aggressive course in PTCL, respectively (126). Here, HDAC6 is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.